Y-mAbs Therapeutics, Inc. Current Assets
Y-mAbs Therapeutics, Inc. had Current Assets of $91.79 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-08-08
- 2025-06-30: Assets, Current $91.79M.
- 2025-03-31: Assets, Current $90.45M.
- 2024-12-31: Assets, Current $98.51M.
- 2024-09-30: Assets, Current $99.06M.
| Period end | Assets, Current |
|---|---|
| 2025-06-30 | $91.79M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $90.45M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $98.51M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $99.06M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $126.76M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $108.27M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $111.11M 10-K · filed 2025-03-04 |
| 2023-09-30 | $114.86M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $115.78M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $124.01M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $130.45M 10-K · filed 2024-02-29 |
| 2022-09-30 | $133.24M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $153.92M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $177.74M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $202.26M 10-K · filed 2023-03-30 |
| 2021-09-30 | $230.58M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $249.37M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $264.01M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $122.36M 10-K · filed 2022-03-01 |
| 2020-09-30 | $133.21M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $163.32M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $189.84M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $211.96M 10-K · filed 2021-03-01 |
| 2019-09-30 | $99.59M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $123.19M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $137.03M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $151.53M 10-K · filed 2020-03-12 |
| 2018-09-30 | $166.04M 10-Q · filed 2018-11-13 |
| 2017-12-31 | $91.36M 10-K · filed 2019-03-22 |